115 related articles for article (PubMed ID: 10695480)
41. An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.
Mazzieri R; D'Alessio S; Kenmoe RK; Ossowski L; Blasi F
Mol Biol Cell; 2006 Jan; 17(1):367-78. PubMed ID: 16267271
[TBL] [Abstract][Full Text] [Related]
42. A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.
Hillig T; Engelholm LH; Ingvarsen S; Madsen DH; Gårdsvoll H; Larsen JK; Ploug M; Danø K; Kjøller L; Behrendt N
J Biol Chem; 2008 May; 283(22):15217-23. PubMed ID: 18362146
[TBL] [Abstract][Full Text] [Related]
43. The urokinase receptor is required for human monocyte chemotaxis in vitro.
Gyetko MR; Todd RF; Wilkinson CC; Sitrin RG
J Clin Invest; 1994 Apr; 93(4):1380-7. PubMed ID: 8163642
[TBL] [Abstract][Full Text] [Related]
44. Intermolecular contact regions in urokinase plasminogen activator receptor.
Liang OD; Bdeir K; Matz RL; Chavakis T; Preissner KT
J Biochem; 2003 Nov; 134(5):661-6. PubMed ID: 14688231
[TBL] [Abstract][Full Text] [Related]
45. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis.
Mukhina S; Stepanova V; Traktouev D; Poliakov A; Beabealashvilly R; Gursky Y; Minashkin M; Shevelev A; Tkachuk V
J Biol Chem; 2000 Jun; 275(22):16450-8. PubMed ID: 10749881
[TBL] [Abstract][Full Text] [Related]
46. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
Resnati M; Pallavicini I; Wang JM; Oppenheim J; Serhan CN; Romano M; Blasi F
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1359-64. PubMed ID: 11818541
[TBL] [Abstract][Full Text] [Related]
47. Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo.
Sidenius N; Sier CF; Blasi F
FEBS Lett; 2000 Jun; 475(1):52-6. PubMed ID: 10854857
[TBL] [Abstract][Full Text] [Related]
48. Crystal structure of the urokinase receptor in a ligand-free form.
Xu X; Gårdsvoll H; Yuan C; Lin L; Ploug M; Huang M
J Mol Biol; 2012 Mar; 416(5):629-41. PubMed ID: 22285761
[TBL] [Abstract][Full Text] [Related]
49. GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis.
Sturge J; Wienke D; East L; Jones GE; Isacke CM
J Cell Biol; 2003 Sep; 162(5):789-94. PubMed ID: 12952933
[TBL] [Abstract][Full Text] [Related]
50. Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis.
Gårdsvoll H; Danø K; Ploug M
J Biol Chem; 1999 Dec; 274(53):37995-8003. PubMed ID: 10608868
[TBL] [Abstract][Full Text] [Related]
51. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.
Bohuslav J; Horejsí V; Hansmann C; Stöckl J; Weidle UH; Majdic O; Bartke I; Knapp W; Stockinger H
J Exp Med; 1995 Apr; 181(4):1381-90. PubMed ID: 7535337
[TBL] [Abstract][Full Text] [Related]
52. Specific immunoassays for detection of intact and cleaved forms of the urokinase receptor.
Piironen T; Laursen B; Pass J; List K; Gårdsvoll H; Ploug M; Danø K; Høyer-Hansen G
Clin Chem; 2004 Nov; 50(11):2059-68. PubMed ID: 15345662
[TBL] [Abstract][Full Text] [Related]
53. Interaction between kringle and growth-factor-like domains in the urokinase molecule: possible role in stimulation of chemotaxis.
Stepanova VV; Beloglazova IB; Gursky YG; Bibilashvily RS; Parfyonova YV; Tkachuk VA
Biochemistry (Mosc); 2008 Mar; 73(3):252-60. PubMed ID: 18393759
[TBL] [Abstract][Full Text] [Related]
54. Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.
Degryse B; Resnati M; Rabbani SA; Villa A; Fazioli F; Blasi F
Blood; 1999 Jul; 94(2):649-62. PubMed ID: 10397732
[TBL] [Abstract][Full Text] [Related]
55. The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors.
Rossi FW; Prevete N; Rivellese F; Napolitano F; Montuori N; Postiglione L; Selleri C; de Paulis A
Transl Med UniSa; 2016 Nov; 15():34-41. PubMed ID: 27896225
[TBL] [Abstract][Full Text] [Related]
56. Soluble human urokinase receptor is composed of two active units.
Higazi AA; Mazar A; Wang J; Quan N; Griffin R; Reilly R; Henkin J; Cines DB
J Biol Chem; 1997 Feb; 272(8):5348-53. PubMed ID: 9030610
[TBL] [Abstract][Full Text] [Related]
57. Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils.
Kindzelskii AL; Eszes MM; Todd RF; Petty HR
Biophys J; 1997 Oct; 73(4):1777-84. PubMed ID: 9336173
[TBL] [Abstract][Full Text] [Related]
58. [Increase of the membrane-bound urokinase level in monocytes from patients with atherosclerosis is accompanied by decrease of urokinase-induced myocyte migration].
Arefieva TI; Krasnikova TL; Parfenova EV; Alekseeva IA
Biull Eksp Biol Med; 1998 Aug; 126(8):147-9. PubMed ID: 9777222
[No Abstract] [Full Text] [Related]
59. Mechanisms of signaling through urokinase receptor and the cellular response.
Koshelnick Y; Ehart M; Stockinger H; Binder BR
Thromb Haemost; 1999 Aug; 82(2):305-11. PubMed ID: 10605718
[No Abstract] [Full Text] [Related]
60. The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation.
Del Rosso M; Margheri F; Serratì S; Chillà A; Laurenzana A; Fibbi G
Curr Pharm Des; 2011; 17(19):1924-43. PubMed ID: 21711238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
